STOCK-BASED COMPENSATION (Tables)

9 Months Ended

Jul. 29, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of reconciliation of the number of options outstanding and exercisable

A reconciliation of the number of options outstanding and exercisable (in thousands) as of July 29, 2018, and changes during the nine months then ended, is as follows:

	Shares	Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Outstanding at October 29, 2017	30,685	$	18.08
Granted	6,272	36.39
Exercised	3,905	10.44
Forfeited	259	36.21
Expired	3	37.76
Outstanding at July 29, 2018	32,790	$	22.35	5.3	$	473,449
Exercisable at July 29, 2018	23,206	$	17.00	3.8	$	457,840

Schedule of weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised

The weighted-average grant date fair value of stock options granted and the total intrinsic value of options exercised (in thousands) during the third quarter and first nine months of fiscal years 2018 and 2017, are as follows. 

	Three Months Ended				Nine Months Ended
	July 29, 2018		July 30, 2017		July 29, 2018		July 30, 2017
Weighted-average grant date fair value	$	7.33	$	—	$	7.16	$	6.41
Intrinsic value of exercised options	$	25,136	$	12,385	$	96,950	$	73,473

Schedule of weighted-average assumptions used to calculate fair value of each option award

The fair value of each option award is calculated on the date of grant using the Black-Scholes valuation model utilizing the following weighted-average assumptions:

	Three Months Ended				Nine Months Ended
	July 29, 2018		July 30, 2017		July 29, 2018		July 30, 2017
Risk-free interest rate	2.9	%	—	%	2.7	%	2.4	%
Dividend yield	2.1	%	—	%	2.1	%	2.0	%
Stock price volatility	19.0	%	—	%	19.0	%	19.0	%
Expected option life	8 years		—		8 years		8 years

Schedule of reconciliation of the nonvested shares

A reconciliation of the restricted shares (in thousands) as of July 29, 2018, and changes during the nine months then ended, is as follows:

	Shares	Weighted- Average Grant Date Fair Value
Restricted at October 29, 2017	58	$	35.62
Granted	52	34.08
Vested	57	35.62
Forfeited	1	35.62
Restricted at July 29, 2018	52	$	34.08

Schedule of the weighted-average grant date fair value of nonvested shares granted, the total fair value of nonvested shares granted, and the fair value of shares that have vested

The weighted-average grant date fair value of restricted shares granted, the total fair value (in thousands) of restricted shares granted, and the fair value (in thousands) of shares that have vested during the first nine months of fiscal years 2018 and 2017, are as follows:

	Nine Months Ended
	July 29, 2018		July 30, 2017
Weighted-average grant date fair value	$	34.08	$	35.62
Fair value of restricted shares granted	1,760		2,080
Fair value of shares vested	2,053		1,920